Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis
Steve Simpson, Bruce Taylor, Dominic E Dwyer, Janette Taylor, Leigh Blizzard, Anne-Louise Ponsonby, Fotini Pittas, Terence Dwyer, Ingrid van der Mei
Multiple Sclerosis | SAGE PUBLICATIONS LTD | Published : 2012
Awarded by Australian National Health & Medical Research Council
Awarded by NHMRC
The MS Longitudinal Study was funded by a grant from the Australian National Health & Medical Research Council (Project 211308). Additional funding for 25(OH) D measures was provided by the Trish Foundation. The HHV-6 and EBV antibody levels were funded by a separate grant from NHMRC (Project 490020). IvM is supported by a fellowship from the Australian Research Council.